• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.安大略省西北部6个基于社区的偏远原住民丁丙诺啡项目评估:回顾性研究。
Can Fam Physician. 2017 Feb;63(2):137-145.
2
Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.在一个存在阿片类药物依赖问题的偏远原住民社区中采取的全社区健康促进措施:在原住民康复计划背景下评估门诊丁丙诺啡 - 纳洛酮替代疗法。
Can Fam Physician. 2015 Feb;61(2):160-5.
3
A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic.一项关于阿片类药物依赖青少年和年轻人在门诊丁丙诺啡/纳洛酮诊所治疗留存率的回顾性研究。
J Addict Med. 2014 May-Jun;8(3):176-82. doi: 10.1097/ADM.0000000000000035.
4
Community strengths in addressing opioid use in Northeastern Ontario.安大略省东北部解决阿片类药物使用问题的社区力量。
Can J Public Health. 2018 Apr;109(2):219-222. doi: 10.17269/s41997-018-0055-4. Epub 2018 Apr 19.
5
Hope in Fort Hope: First Nations community is winning the battle against prescription drug abuse.霍普堡的希望:原住民社区正在赢得对抗处方药滥用的战斗。
Can Fam Physician. 2013 Apr;59(4):391-3.
6
Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.桑迪飓风过后六个月,基于办公室的丁丙诺啡项目中的精神疾病共病与物质使用结果
Subst Use Misuse. 2015;50(12):1571-8. doi: 10.3109/10826084.2015.1023455. Epub 2015 Nov 19.
7
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.在一项多中心试验中,随机接受丁丙诺啡/纳洛酮治疗的患者与接受美沙酮治疗的患者相比,治疗保留率情况。
Addiction. 2014 Jan;109(1):79-87. doi: 10.1111/add.12333. Epub 2013 Oct 9.
8
Buprenorphine treatment in an urban community health center: what to expect.城市社区卫生中心的丁丙诺啡治疗:预期效果
Fam Med. 2008 Jul-Aug;40(7):500-6.
9
Geographic and specialty distribution of US physicians trained to treat opioid use disorder.接受过治疗阿片类药物使用障碍培训的美国医生的地理分布和专业分布。
Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.
10
Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.准备和康复:美沙酮和丁丙诺啡/纳洛酮转换治疗阿片类药物使用障碍。
Int J Ment Health Nurs. 2019 Feb;28(1):226-236. doi: 10.1111/inm.12523. Epub 2018 Jul 18.

引用本文的文献

1
Retention in Opioid Agonist Therapy Among First Nations People.原住民接受阿片类激动剂治疗的留存情况。
JAMA Netw Open. 2025 Jun 2;8(6):e2518452. doi: 10.1001/jamanetworkopen.2025.18452.
2
Patient experience of an abstinence-based Indigenous residential treatment program in Northern Ontario: a descriptive qualitative study.安大略省北部一个基于禁欲的原住民住院治疗项目的患者体验:一项描述性定性研究。
Front Health Serv. 2024 Dec 24;4:1387184. doi: 10.3389/frhs.2024.1387184. eCollection 2024.
3
An Indigenous-led buprenorphine-naloxone treatment program to address opioid use in remote Northern Canada.一项由原住民主导的丁丙诺啡-纳洛酮治疗项目,旨在解决加拿大北部偏远地区的阿片类药物使用问题。
Dialogues Health. 2024 Sep 1;5:100190. doi: 10.1016/j.dialog.2024.100190. eCollection 2024 Dec.
4
'I'm on the coast and I'm on methadone': A qualitative study examining access to opioid agonist treatment in rural and coastal British Columbia.“我在沿海地区,我在用美沙酮”:一项在不列颠哥伦比亚省农村和沿海地区考察阿片类激动剂治疗获取途径的定性研究。
Can J Rural Med. 2024 Jul 1;29(3):117-124. doi: 10.4103/cjrm.cjrm_56_23. Epub 2024 Aug 20.
5
Understanding and Addressing Widening Racial Inequalities in Drug Overdose.理解并解决药物过量导致的日益严重的种族不平等问题。
Am J Psychiatry. 2024 May 1;181(5):381-390. doi: 10.1176/appi.ajp.20230917.
6
A realist review of best practices and contextual factors enhancing treatment of opioid dependence in Indigenous contexts.在原住民背景下增强阿片类药物依赖治疗的最佳实践和情境因素的现实主义综述。
Harm Reduct J. 2023 Mar 17;20(1):34. doi: 10.1186/s12954-023-00740-x.
7
Grounding Wellness: Coloniality, Placeism, Land, and a Critique of "Social" Determinants of Indigenous Mental Health in the Canadian Context.扎根健康:殖民主义、地方主义、土地以及对加拿大语境下“社会”因素对原住民心理健康影响的批判。
Int J Environ Res Public Health. 2023 Feb 28;20(5):4319. doi: 10.3390/ijerph20054319.
8
A scoping review of opioid harm reduction interventions for equity-deserving populations.针对应受公平对待人群的阿片类药物危害减少干预措施的范围综述。
Lancet Reg Health Am. 2022 May 11;12:100271. doi: 10.1016/j.lana.2022.100271. eCollection 2022 Aug.
9
Implementation and evaluation of a two-eyed seeing approach using traditional healing and seeking safety in an indigenous residential treatment program in Northern Ontario.安大略省北部传统疗愈和寻求安全的原住民住院治疗项目中,实施并评估双眼观察方法。
Int J Circumpolar Health. 2022 Dec;81(1):2125172. doi: 10.1080/22423982.2022.2125172.
10
Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review.在加拿大农村和偏远社区实施阿片类激动剂治疗的障碍和促进因素:综合评价。
Subst Abuse Treat Prev Policy. 2022 Aug 26;17(1):62. doi: 10.1186/s13011-022-00463-5.

本文引用的文献

1
Evaluation of an inpatient medical withdrawal program in rural Ontario: a 1-year prospective study.安大略省农村地区住院医疗戒毒项目评估:一项为期1年的前瞻性研究。
Can J Rural Med. 2015 Summer;20(3):92-7.
2
Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.在一个存在阿片类药物依赖问题的偏远原住民社区中采取的全社区健康促进措施:在原住民康复计划背景下评估门诊丁丙诺啡 - 纳洛酮替代疗法。
Can Fam Physician. 2015 Feb;61(2):160-5.
3
Family history of alcohol and drug abuse, childhood trauma, and age of first drug injection.酒精和药物滥用家族史、童年创伤以及首次注射毒品的年龄。
Subst Use Misuse. 2014 Aug;49(10):1311-6. doi: 10.3109/10826084.2014.901383. Epub 2014 Apr 7.
4
Primary care patient characteristics associated with completion of 6-month buprenorphine treatment.与完成 6 个月丁丙诺啡治疗相关的初级保健患者特征。
Addict Behav. 2013 Nov;38(11):2724-8. doi: 10.1016/j.addbeh.2013.07.007. Epub 2013 Jul 25.
5
Engagement, retention, and abstinence for three types of opioid users in Florida.佛罗里达州三类阿片类药物使用者的参与度、留存率及戒断情况。
Subst Use Misuse. 2013 Jun;48(8):623-34. doi: 10.3109/10826084.2013.800112. Epub 2013 Jun 10.
6
Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).丁丙诺啡/纳洛酮和美沙酮维持治疗阿片类镇痛药、海洛因和联合使用者的治疗结局:从使用阿片类激动剂替代疗法(START)开始治疗的结果。
J Stud Alcohol Drugs. 2013 Jul;74(4):605-13. doi: 10.15288/jsad.2013.74.605.
7
Safety, effectiveness and tolerance of buprenorphine-naloxone in the treatment of opioid dependence: results from a nationwide non-interventional study in routine care.丁丙诺啡-纳洛酮治疗阿片类药物依赖的安全性、有效性和耐受性:一项全国性常规护理中非干预性研究的结果。
Pharmacopsychiatry. 2013 May;46(3):94-107. doi: 10.1055/s-0032-1330033. Epub 2013 Jan 4.
8
Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations.阿片类药物维持治疗作为纽约市阿片类药物依赖者的减少伤害工具:有必要扩大在边缘化人群中使用丁丙诺啡/纳洛酮的机会。
J Addict Dis. 2012;31(3):278-87. doi: 10.1080/10550887.2012.694603.
9
Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds.丁丙诺啡与美沙酮治疗:发达国家和发展中国家的证据综述。
J Neurosci Rural Pract. 2012 Jan;3(1):45-50. doi: 10.4103/0976-3147.91934.
10
Narcotic-exposed neonates in a First Nations population in northwestern Ontario: incidence and implications.安大略省西北部第一民族人群中暴露于麻醉剂的新生儿:发生率和影响。
Can Fam Physician. 2011 Nov;57(11):e441-7.

安大略省西北部6个基于社区的偏远原住民丁丙诺啡项目评估:回顾性研究。

Evaluation of 6 remote First Nations community-based buprenorphine programs in northwestern Ontario: Retrospective study.

作者信息

Mamakwa Solomon, Kahan Meldon, Kanate Dinah, Kirlew Mike, Folk David, Cirone Sharon, Rea Sara, Parsons Pierre, Edwards Craig, Gordon Janet, Main Fiona, Kelly Len

机构信息

Health Director for the Shibogama Health Authority in Sioux Lookout, Ont.

Associate Professor in the Department of Family Medicine at the University of Toronto in Ontario and is an advisor in addiction care to Sioux Lookout physicians.

出版信息

Can Fam Physician. 2017 Feb;63(2):137-145.

PMID:28209683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5395389/
Abstract

OBJECTIVE

To evaluate established opioid addiction treatment programs that use traditional healing in combination with buprenorphine-naloxone maintenance treatment in 6 First Nations communities in the Sioux Lookout region of northwestern Ontario.

DESIGN

Retrospective cohort study.

SETTING

Six First Nations communities in northwestern Ontario.

PARTICIPANTS

A total of 526 First Nations participants in opioid-dependence treatment programs.

INTERVENTION

Buprenorphine-naloxone substitution therapy and First Nations healing programming.

MAIN OUTCOME MEASURES

Retention rates and urine drug screening (UDS) results.

RESULTS

Treatment retention rates at 6, 12, and 18 months were 84%, 78%, and 72%, respectively. We estimate that the rate at 24 months will also be more than 70%. The UDS programming varied and was implemented in only 1 community. Initially urine testing was voluntary and it then became mandatory. Screening with either method found the proportion of urine samples with negative results for illicit opioids ranged between 84% and 95%.

CONCLUSION

The program's treatment retention rates and negative UDS results were higher than those reported for most methadone and buprenorphine-naloxone programs, despite a patient population where severe posttraumatic stress disorder is endemic, and despite the programs' lack of resources and addiction expertise. Community-based programs like these overcome the initial challenge of cultural competence. First Nations communities in other provinces should establish their own buprenorphinenaloxone programs, using local primary care physicians as prescribers. Sustainable core funding is needed for programming, long-term aftercare, and trauma recovery for such initiatives.

摘要

目的

评估安大略省西北部苏圣洛朗地区6个原住民社区中,将传统疗法与丁丙诺啡 - 纳洛酮维持治疗相结合的既定阿片类药物成瘾治疗项目。

设计

回顾性队列研究。

地点

安大略省西北部的6个原住民社区。

参与者

共有526名参与阿片类药物依赖治疗项目的原住民。

干预措施

丁丙诺啡 - 纳洛酮替代疗法和原住民康复项目。

主要观察指标

留存率和尿液药物筛查(UDS)结果。

结果

6个月、12个月和18个月时的治疗留存率分别为84%、78%和72%。我们估计24个月时的留存率也将超过70%。UDS项目各不相同,仅在1个社区实施。最初尿液检测是自愿的,后来变为强制性的。两种方法筛查发现,非法阿片类药物检测结果为阴性的尿液样本比例在84%至95%之间。

结论

尽管患者群体中创伤后应激障碍高发,且项目缺乏资源和成瘾专业知识,但该项目的治疗留存率和UDS阴性结果高于大多数美沙酮和丁丙诺啡 - 纳洛酮项目报告的结果。此类基于社区的项目克服了文化能力方面的最初挑战。其他省份的原住民社区应建立自己的丁丙诺啡 - 纳洛酮项目,由当地初级保健医生担任开处方者。此类举措的项目规划、长期后续护理和创伤恢复需要可持续的核心资金。